Rebecca M. Shulman, MD

Request Appointment

Specialties

Radiation Oncology, Sarcoma and Connective Tissue Radiation Oncology, Breast Radiation Oncology

4.9

65 Patient Satisfaction Ratings

About Me

Ratings & Reviews

Publications

About Me

Research Interests

Combining biological discoveries, including our expanding knowledge of inflammatory and immune cellular mechanisms, with the innovative techniques of precision radiotherapy to devise effective cancer treatments

Languages

Spanish
English

Education

2021-2022 Chief Resident, Fox Chase Cancer Center, Philadelphia, PA 19111
2019-2023 Resident, Fox Chase Cancer Center, Philadelphia, PA 19111
2018-2019 Intern, Crozer Chester Medical Center, Chester, PA 19013
2014-2018 MD, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140
2009-2013 BA, Psychology, New York University, New York, NY 10012

Board Certifications

American Board of Radiology - Radiation Oncology

Memberships

American Society of Therapeutic Radiology (ASTRO)
American Society of Clinical Oncology (ASCO)
Radiological Society of North America (RSNA)

Awards and Honors

2023-2025 Robert A. Winn Diversity in Clinical Trials: Career Development Award. “NRG BR007: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-negative, Oncotype Recurrence Score ≤ 18 Breast Cancer (DEBRA)”
2023-2024 ASTRO-BCRF Emerging Investigator Award. “Combination therapy with radiotherapy, immune checkpoint blockade, and curaxin enhances tumor regression in metastatic triple-negative breast cancer”
2022-2024 LUNGevity Health Equity and Inclusiveness Research Fellow Award. “Synergistic expression of combined RT and dual-immune checkpoint blockade”
2021-2022 Conquer Cancer Foundation ASCO Young Investigator Award. “Genotyping of BRCA1 mutations predicts radio sensitivity in breast cancers and in cultured breast cancer cells.”
2021-2022 In Vino Vita Young Investigator Award. “Genotyping of BRCA1 mutations predicts radio sensitivity in breast cancers and in cultured breast cancer cells.”
2022 RSNA Roentgen Resident/Fellow Research Award
2022 ECOG-ACRIN Group Meeting Spring 2022 Travel Grant
2021-2022 AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship
2022 Alpha Omega Alpha Honor Society
2020 Harvard Macy Program for Postgraduate Trainees: Future Academic Clinician Educators
2017 Gold Humanism Honor Society
2016 Conwell Scholar Award
2016 American Balint Essay Contest Winner
2016 Tractenberg Ethics Essay Contest Finalist
2015 Conwell Scholar Award
2014 Conwell Scholar Award

2023-2025 Robert A. Winn Diversity in Clinical Trials: Career Development Award. “NRG BR007: A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER2-negative, Oncotype Recurrence Score ≤ 18 Breast Cancer (DEBRA)”
2023-2024 ASTRO-BCRF Emerging Investigator Award. “Combination therapy with radiotherapy, immune checkpoint blockade, and curaxin enhances tumor regression in metastatic triple-negative breast cancer”
2022-2024 LUNGevity Health Equity and Inclusiveness Research Fellow Award. “Synergistic expression of combined RT and dual-immune checkpoint blockade”
2021-2022 Conquer Cancer Foundation ASCO Young Investigator Award. “Genotyping of BRCA1 mutations predicts radio sensitivity in breast cancers and in cultured breast cancer cells.”
2021-2022 In Vino Vita Young Investigator Award. “Genotyping of BRCA1 mutations predicts radio sensitivity in breast cancers and in cultured breast cancer cells.”
2022 RSNA Roentgen Resident/Fellow Research Award
2022 ECOG-ACRIN Group Meeting Spring 2022 Travel Grant
2021-2022 AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship
2022 Alpha Omega Alpha Honor Society
2020 Harvard Macy Program for Postgraduate Trainees: Future Academic Clinician Educators
2017 Gold Humanism Honor Society
2016 Conwell Scholar Award
2016 American Balint Essay Contest Winner
2016 Tractenberg Ethics Essay Contest Finalist
2015 Conwell Scholar Award
2014 Conwell Scholar Award

Ratings & Reviews

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Overall Care

4.9

Explained Things Clearly

4.9

Showed Courtesy & Respect

4.9

Discussed Treatment Options

4.9

Recommend Provider

4.9

Patient Comments

4.9 out of 5 (65 ratings, 7 comments)

04/15/2026

Very happy with Dr. Schulman and her team. They are excellent.

08/18/2025

Everything was excellent.

08/18/2025

My experience was very good.

06/02/2025

Very caring Dr.

05/28/2025

Dr Shulman is a very kind, caring and knowledgeable doctor. Everyone I interacted with in the radiation department is also very friendly and caring.

Offices

Fox Chase Cancer Center

333 Cottman Avenue

Philadelphia, PA 19111

Phone: 888-369-2427

Publications

My NCBI

1.   Shulman RM, Weinberg DS, Ross EA, et al. Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine. J Natl Compr Canc Netw. 2022;20(2):160-166. doi:10.6004/jnccn.2021.7113. PubMed PMID: 35130494
2.   Shulman RM, Meyer JE. Current Trends in the Treatment of Locally Advanced Rectal Cancer: Where We Are and How We Got Here. Curr Colorectal Cancer Rep 17, 88–102 (2021). https://doi.org/10.1007/s11888-021-00471-w
3.   Shulman RM, Galloway TJ. A Hard Case to Swallow: Multiple Primary Cancers With Multiple Possible Answers in the Setting of Solid Organ Transplantation. International Journal of Radiation Oncology*Biology*Physics. 2022;112(3):584-585. doi:10.1016/j.ijrobp.2021.11.004
4.   Shulman RM, Meyer JM. Current Trends in the Treatment of Locally Advanced Rectal Cancer. ASCO Daily News, January 2021.
5.   Shulman RM, Meyer JE. Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers after Chemoradiation. Ann Surg Oncol. 2020. PMID: 32804323.
6.   Shulman RM, Meyer JE, Li T, Howell KJ. External beam radiation therapy (EBRT) for asymptomatic bone metastases in patients with solid tumors reduces the risk of skeletal-related events (SREs). Ann Palliat Med. 2019 Apr;8(2):159-67. PMID: 30525770.
7.   Shulman RM. and Abbas, A.E. The state of the art and future directions of robotic-assisted thoracic surgery. Ind J Thorac Cardiovasc Surg. 2018; 34: 40–46.